Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Gastroesophageal Cancer
How would you treat a patient with adenocarcinoma of the GE junction in the setting of interstitial lung disease?
Is neoadjuvant chemoradiation or perioperative chemotherapy preferred?
Answer from: Radiation Oncologist at Academic Institution
Protons.
Sign in or Register to read more
6623
Related Questions
How do you approach repeat SBRT in the abdomen, specifically when considering constraints for bowel and mesenteric vessels?
Do you always biopsy suspicious liver lesions if you have a biopsy from the pancreatic mass showing PDAC?
In a patient with prior RT to the prostate and SVs and newly diagnosed, locally advanced rectal cancer at 10-15 cm, would you offer preoperative chemoradiation?
Would you change treatment approach for rectal cancer with an associated intussusception?
Would you consider chemo-RT for duodenal adenocarcinoma s/p resection with at least 1 cm positive margin in a patient with a history of Crohn's disease?
When treating pancreatic body/tail lesions that result in significant dose spread to the spleen, what is your threshold to offer pneumococcal, hemophilus influenza, and meningococcal vaccines?
When treating esophageal cancer with post operative radiation, what, if any, are some strategies to minimize the risk of complications at the site of surgical anastomosis?
What are your top takeaways from ASCO GI 2025?
Would you consider proton therapy as part of TNT for rectal cancer?
How do you sequence hypofractionated radiation and systemic therapy for patients with unresectable cholangiocarcinoma?